Their Headline reads

Veterans targeted by medicinal cannabis businesses on social media spruiking free products and subscriptions.

In short:

Veterans are being targeted by social media ads offering access to “free” medicinal cannabis, funded by the Department of Veterans Affairs (DVA).

VeteranCann supplied medicinal cannabis to a man with a record of cannabis addiction, who ended up in “borderline psychosis” and kept sending it even after he told them he was addicted.

Another patient was bombarded with texts to book an appointment, as the DVA confirms it funded $35.99 million of medicinal cannabis in 2023/2024.

The Report

At 4:16am a Brisbane navy veteran is desperately messaging the company which prescribes and sends him medicinal cannabis.

It had been a swift downward spiral for 35-year-old Bill*, after he was targeted with a Facebook advertisement by the company VeteranCann.

The ads offered free access to “natural therapies” and claimed it was “backed by the Department of Veterans Affairs (DVA)”.

Despite his history of cannabis addiction being well-documented with the DVA, Bill was sent more than $1,700 worth of medicinal cannabis in less than a month after just one call with a VeteranCann doctor.

The 14 bottles — six containing the psychoactive ingredient tetrahydrocannabinol (THC) — were paid for by the DVA.

Struggling with his mental health, chronic pain and life with a newborn baby, some days Bill would drink entire bottles of the oil — bottles which should have lasted almost a month.

Within weeks he was in a “borderline drug-induced psychosis”, had taken sick leave from work and told his wife, who was caring for their baby, he felt like a “zombie”.

Despite informing VeteranCann he was addicted, he received another two shipments of the drugs.

“What is wrong with this system? Why should addictive medication be sent three times to a drug-addicted veteran?” he said.

Veterans big business for medicinal cannabis telehealth companies

Veterans represent a lucrative market for medicinal cannabis companies.

The DVA fully funds medicinal cannabis for veterans with specific conditions when other treatments have failed, and where there is evidence of a clinical benefit.

In the 2023-2024 financial year, it spent $35.99 million to fund medicinal cannabis for 8,455 veterans.

A DVA spokesperson confirmed 6 per cent of applications to fund medicinal cannabis products for veterans were rejected.

The ABC has spoken to veterans accusing major industry players of exploitative behaviour, including questionable marketing tactics, late night texts, offers of “free” medicinal cannabis, and ads targeting them through veteran support groups.

Army veteran Sandra* started the process to access medicinal cannabis for chronic pain through VeteranCann this year.

She said she had a 20-minute consultation with a nurse before being prescribed cannabis oil containing THC by a doctor she never spoke to.

The Royal Australian College of Psychiatrists warns products which contain high potency THC — the ingredient which gives users a “high” — should be avoided due to the risk of psychosis and weak evidence of efficacy in most conditions.

The DVA requires a written application from a veteran’s specialist before approving funding for higher doses of THC, or for multiple cannabis products.

VeteranCann invites veterans to use its “in-house advocate program” to get chronic pain or injury officially accepted by the DVA, as well as access to “partnered pain specialists” to unlock fully-funded treatment — including higher dose THC.

Sandra’s regular GP, Dr Kerry Summerscales, is a veteran herself.

She specialises in treating other veterans, and was shocked to see some of the high strength products her patients had been prescribed by online telehealth companies.

“I was really quite horrified on a few levels,” Dr Summerscales said.

VeteranCann booked appointments for both Bill and Sandra with a “pain specialist” doctor, to help get DVA funding for higher doses of THC.

When Sandra didn’t follow up, she started receiving texts from a man called Geoff from VeteranCann offering to help gain free access to medicinal cannabis including “oil, flower and gummy bears”.

“The texts were a bit weird, because they just kept coming,” Sandra, who also lives with PTSD and ADHD, said.

Dr Summerscales said she was stunned when she saw the messages.

“I saw it as downright badgering, especially when you look at the times, at 9 o’clock at night there were texts,” she said.

Eventually Sandra replied to Geoff, noting VeteranCann hadn’t consulted with her GP.

Geoff responded, “normally VeteranCann doctors don’t liaise with GPs”, before texting again to offer a follow-up call.

“Therein lies the issue,” Dr Summerscales said.

“(Veterans) do have chronic pain and some of them do have mental health issues and they are vulnerable in that way.

“If you’re not treating the patient holistically and you’re just prescribing the one medication in a five-minute consult, that’s not medicine. And that is what needs to be clamped down on.”

In a statement, VeteranCann told the ABC Geoff was a “trained and experienced veteran advocate” paid for “onboarding veterans”, but apologised for the messages which it said “should not have been sent”.

Geoff’s number was also featured in online veteran support groups, advertising VeteranCann including several run by registered charity Young Veterans

Read more including this

VeteranCann consultant terminated after misogynistic posts

VeteranCann is owned by Dispensed, a telehealth company under fire after patients with a history of psychosis were prescribed medicinal cannabis by the company. One was hospitalised and the other took his own life.

https://www.abc.net.au/news/2024-11-11/veterans-targeted-medicinal-cannabis-businesses-veterancann/104563180

1906 sells two different “drops,” or pills, with low doses of THC and higher amounts of caffeine marketed as “Go” and “Genius” in small cylinder containers.

The firm’s “Go” drops contain 80 milligrams of caffeine and 2 mgs of THC-extract and 5 mgs of cannabidiol [CBD]/ weed extract and other plant-based or herbal ingredients. Go is marketed as an energy stimulant.

Its Genius pills contain 20 mgs of caffeine mixed with 2.5 mgs of TCH and 5 mgs combined of CBD and Cannabigerol (CBG), also found in the marijuana plant, and other herbal or plant extracts. It’s touted as a “brain power” supplement to boost focus and memory and calmness.

The 1906 cannabis pills have been marketed in New York since February of last year.

But OCM regulators issued a “quarantine,” or stop order, for the 1906 tablet July 24 after inspecting the 1906 combined cannabis-caffeine mix products at the Hudson Cannabis facility.

“Evidence supports that ingredients used in product are not allowed to be used in cannabis products,” said the quarantine order signed by inspectors Natalie DeLong and Matthew Hinken.

The order said the mixed ingredients “may jeopardize public health or safety.”

The company marketing 1906, which has been sold in seven states including New York, is appealing the ruling banning the sale of $1 million of its inventory in New York.

“Hudson Cannabis and our production facilities fully follow New York State’s cannabis regulations,” said Melany Dobson, co-founder of Hudson Cannabis, in a statement to The Post on Sunday.

“We are surprised by this decision from the State to quarantine products that have been on the market for over 18 months, are sold legally in States across the nation, and as far as we know have had zero reported adverse effects.

“This type of arbitrary and capricious behavior, preventing the sale of safe and tested products readily available across the country, only serves to benefit the illicit market Governor Hochul claims to care about shutting down,” Dobson said.

A lawyer for 1906’s parent firm Nuka Enterprises, Matthew Schweber, said OCM cited what he described as a wacky decaffeination rule that forbids infusing pure caffeine into cannabis products but allows “naturally occurring caffeine.”

The rule states,  “A processor is prohibited from processing any products which… contain any non-phytocannabinoid ingredient that would increase potency, toxicity, or addictive potential, or that would create an unsafe combination, known or unknown, with other psychoactive substances. This prohibition shall not apply to products containing naturally occurring caffeine, such as coffee, tea, or chocolate.”

OCM claims that caffeine increases “potency, toxicity, or addictive potential or… create(s) an unsafe combination [with cannabinoids],” Schweber said.

“But OCM can’t say which prohibition exactly caffeine triggers? Does caffeine increase cannabis’ ‘potency?’ Does it increase its ‘toxicity’ or its ‘addictive potential?’  Does it create ‘an unsafe combination?’ ” Schweber said.

“They can’t say. Do they have documented evidence of any of the dangers of combining caffeine and cannabis? No, of course not,” the lawyer said.

Schweber said the “crazy” part is that state regulators don’t explain why “naturally occurring caffeine” is OK but added caffeine is not.

Read more https://nypost.com/2024/10/27/us-news/ny-bans-sale-of-caffeine-infused-cannabis/

Green Market Report

New Jersey Gov. Phil Murphy on Friday appointed medical business executive Amelia Mapp, the wife of Plainfield Mayor Adrian Mapp, to replace an outgoing member of the state Cannabis Regulatory Commission.

Mapp is taking over for Commissioner Charles Barker, who is departing the agency after serving on the panel since 2021, where he developed a reputation for being critical of the Murphy administration’s efforts on social justice within the cannabis sector and of the outsized role that large corporations have taken in the state’s marijuana trade, NJ.com reported.

Read full report at 

Shakeup at New Jersey cannabis commission

Also see 

https://www.nj.com/politics/2024/09/murphy-boots-leading-critic-of-big-weed-corporations-from-nj-cannabis-commission.html